Treatment Strategies and Individualized Timing
At a Glance
Non-24 treatment works by carefully timing tasimelteon, melatonin, light, darkness, and daily routines to anchor the body clock to a 24-hour day. The schedule must be individualized and maintained consistently because mistimed or missed treatment can restart the drift.
Disclaimer: Do not start, stop, or change the timing of prescription medications, melatonin, or light therapy without guidance from a healthcare provider.
Treating Non-24 is fundamentally different from treating general insomnia. The goal is not just to “knock you out” for the night, but to entrain your internal clock—essentially “tethering” your biological rhythm to the 24-hour day so it stops drifting [1].
This process, known as chronotherapy, requires precise timing. If treatments are used at the wrong time, they can actually make the drift worse or stabilize your clock at an inconvenient time (like being wide awake until 4:00 AM every night) [2][3].
Strategies for Totally Blind Individuals
Because the brain cannot see light to reset the clock, treatment focuses on using “chemical signals” to tell the brain when night begins [2].
-
Tasimelteon (Hetlioz): This is the first FDA-approved medication specifically for Non-24 in totally blind adults [4]. It works by mimicking melatonin and is a melatonin-receptor agonist at MT1 and MT2 [5].
- Standard Dose: 20 mg taken once daily [5].
- Crucial Timing: It must be taken at the same time every night, typically one hour before your target bedtime, depending on the prescribing information and specialist guidance [5].
- Maintenance: Treatment is usually long-term; in studies, 80% of people who stopped the medication lost their 24-hour rhythm and began drifting again [6].
- Side Effects: The most common issues include headaches, nightmares or unusually vivid dreams, somnolence, and elevated liver enzymes [4][5].
- Interactions: Your doctor must know if you smoke (which reduces the drug’s effectiveness) or take medications like fluvoxamine (which can dangerously increase drug levels) or rifampin (which can lower them) [7].
-
Low-Dose Melatonin: While the evidence is less robust than for Tasimelteon, the American Academy of Sleep Medicine (AASM) suggests timed melatonin as an option [8].
- The “Low and Early” Rule: Unlike using melatonin as a sedative, entrainment often uses a very low dose (around 0.5 mg) [2].
- Timing: To “pull” the clock earlier, it is sometimes taken several hours before your desired bedtime, but the exact timing must be individualized based on your biological phase [2]. Taking it right at bedtime may stabilize your rhythm but often results in an “undesirably late phase,” where you are still awake much of the night [2][3]. Note that over-the-counter melatonin varies in purity and dose.
Strategies for Sighted Individuals
For sighted people, treatment is more complex and often combines light, medication, and strict behavioral cues [1]. The evidence for sighted treatments is limited and variable.
- Bright Light Therapy: This involves sitting in front of a specialized “light box” (usually 10,000 lux) for 30 to 60 minutes [9].
- Morning Reset: Light is typically used at a specific phase guided by your specialist to “anchor” the start of the day [10]. You should consult an ophthalmologist if you have retinal conditions or take photosensitizing medications, and watch for mood activation if you have bipolar-spectrum illness.
- The Evening Block: Just as important as morning light is evening darkness. You may be advised to wear blue-light-blocking glasses or avoid all screens for several hours before bed to prevent evening light from “pushing” your clock later [1][11].
- Combination Therapy: Many sighted patients find the most success by combining morning light with low-dose evening melatonin [3]. This creates a “push-pull” effect that helps the SCN (the master clock) stay locked into a 24-hour cycle [12].
The Maintenance Challenge
Entrainment is not a “cure”; it is a management strategy. Even after you successfully lock into a 24-hour schedule, your clock still “wants” to drift [5]. Missing even a few days of light therapy or medication, or being exposed to bright light at 2:00 AM, can “break the tether” and restart the drift [6][11]. Ongoing coordination with a sleep specialist is essential to adjust timing as your lifestyle or environment changes [1].
Common questions in this guide
What is the main goal of treatment for Non-24?
What is tasimelteon used for in Non-24?
How should melatonin be timed for a drifting body clock?
Can bright light therapy help sighted people with Non-24?
Can taking melatonin or using light at the wrong time make Non-24 worse?
Do treatments for Non-24 need to continue after my sleep schedule improves?
Which medicines or habits can affect tasimelteon?
Get notified when new evidence is published on Non-24-hour sleep-wake syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
Non-24-hour Sleep-Wake Rhythm Disorder.
Abbott SM
Neurologic clinics 2019; (37(3)):545-552 doi:10.1016/j.ncl.2019.03.002.
PMID: 31256788 - 2
Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind.
Emens JS, Eastman CI
Drugs 2017; (77(6)):637-650 doi:10.1007/s40265-017-0707-3.
PMID: 28229310 - 3
Diagnostic and Treatment Challenges of Sighted Non-24-Hour Sleep-Wake Disorder.
Malkani RG, Abbott SM, Reid KJ, Zee PC
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2018; (14(4)):603-613 doi:10.5664/jcsm.7054.
PMID: 29609703 - 4
Safety profile of tasimelteon, a melatonin MT1 and MT2 receptor agonist: pooled safety analyses from six clinical studies.
Leger D, Quera-Salva MA, Vecchierini MF, et al.
Expert opinion on drug safety 2015; (14(11)):1673-85 doi:10.1517/14740338.2015.1093112.
PMID: 26393492 - 5
Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials.
Lockley SW, Dressman MA, Licamele L, et al.
Lancet (London, England) 2015; (386(10005)):1754-64.
PMID: 26466871 - 6
Tasimelteon for treating non-24-h sleep-wake rhythm disorder.
Nishimon S, Nishimon M, Nishino S
Expert opinion on pharmacotherapy 2019; (20(9)):1065-1073 doi:10.1080/14656566.2019.1603293.
PMID: 30990759 - 7
Clinical assessment of drug-drug interactions of tasimelteon, a novel dual melatonin receptor agonist.
Ogilvie BW, Torres R, Dressman MA, et al.
Journal of clinical pharmacology 2015; (55(9)):1004-11 doi:10.1002/jcph.507.
PMID: 25851638 - 8
Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline.
Auger RR, Burgess HJ, Emens JS, et al.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2015; (11(10)):1199-236 doi:10.5664/jcsm.5100.
PMID: 26414986 - 9
[Treating circadian sleep-wake disorders by light].
Leger D, Duforez F, Gronfier C,
Presse medicale (Paris, France : 1983) 2018; (47(11-12 Pt 1)):1003-1009 doi:10.1016/j.lpm.2018.10.013.
PMID: 30413331 - 10
Sleep deprivation therapy to reset the circadian pacemaker in a non-24-hour sleep-wake disorder: a case report.
Guichard K, Micoulaud-Franchi JA, Philip P, Taillard J
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2021; (17(7)):1503-1506 doi:10.5664/jcsm.9294.
PMID: 33792535 - 11
Behaviorally and environmentally induced non-24-hour sleep-wake rhythm disorder in sighted patients.
Emens JS, St Hilaire MA, Klerman EB, et al.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2022; (18(2)):453-459 doi:10.5664/jcsm.9612.
PMID: 34402783 - 12
Beyond the limits of circadian entrainment: Non-24-h sleep-wake disorder, shift work, and social jet lag.
Diekman CO, Bose A
Journal of theoretical biology 2022; (545()):111148 doi:10.1016/j.jtbi.2022.111148.
PMID: 35513166
This page is for informational purposes only and does not constitute medical advice. Do not start, stop, or change tasimelteon, melatonin, light therapy, or their timing without guidance from a qualified healthcare provider.